We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-16.98%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$4.68B
AUM Growth
-$1.71B
Cap. Flow
-$462M
Cap. Flow %
-9.88%
Top 10 Hldgs %
25.31%
Holding
149
New
16
Increased
23
Reduced
54
Closed
13

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$59.6M
2
GTM
ZoomInfo Technologies
GTM
+$19.8M
3
CMS icon
CMS Energy
CMS
+$19.8M
4
GH icon
Guardant Health
GH
+$18.2M
5
LNG icon
Cheniere Energy
LNG
+$15.6M

Top Sells

Rank Stock Value
1
DT icon
Dynatrace
DT
+$112M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$64.6M
3
SMAR
Smartsheet Inc.
SMAR
+$38.2M
4
ROP icon
Roper Technologies
ROP
+$32.9M
5
LRCX icon
Lam Research
LRCX
+$31.8M

Sector Composition

Rank Sector Weight
1 Healthcare 35.3%
2 Technology 26.13%
3 Industrials 16.22%
4 Consumer Discretionary 5.49%
5 Utilities 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTG icon
26
Entegris
ENTG
$17.8B
$59.6M 1.27%
646,630
-180,170
-22% -$19.5M
CCI icon
27
Crown Castle
CCI
$33.4B
$58.8M 1.26%
349,500
+16,300
+5% +$2.97M
SPT icon
28
Sprout Social
SPT
$509M
$57.5M 1.23%
990,943
-59,000
-6% -$3.43M
GNRC icon
29
Generac Holdings
GNRC
$11.3B
$56.8M 1.21%
269,700
-102,400
-28% -$25.2M
LNG icon
30
Cheniere Energy
LNG
$54.1B
$54.2M 1.16%
407,300
+114,900
+39% +$15.6M
TREX icon
31
Trex
TREX
$4.56B
$53.9M 1.15%
990,000
– –
EXAS
32
DELISTED
Exact Sciences
EXAS
$53.8M 1.15%
1,365,600
-124,400
-8% -$6.65M
DOCS icon
33
Doximity
DOCS
$3.82B
$52.7M 1.13%
+1,512,602
New +$59.6M
DHI icon
34
D.R. Horton
DHI
$40.7B
$51.7M 1.11%
781,500
-280,000
-26% -$19.7M
LRCX icon
35
Lam Research
LRCX
$372B
$48.4M 1.03%
1,135,000
-668,460
-37% -$31.8M
DDOG icon
36
Datadog
DDOG
$95.6B
$48.3M 1.03%
506,619
+11,619
+2% +$1.28M
XMTR icon
37
Xometry
XMTR
$4.69B
$47.6M 1.02%
1,404,164
+204,112
+17% +$7.04M
GLBE icon
38
Global E Online
GLBE
$6.7B
$47.5M 1.02%
2,353,371
-142,020
-6% -$3.26M
COLL icon
39
Collegium Pharmaceutical
COLL
$1.17B
$46.6M 1%
2,629,593
– –
COGT icon
40
Cogent Biosciences
COGT
$7.07B
$46M 0.98%
5,095,000
+1,195,000
+31% +$8.16M
MPWR icon
41
Monolithic Power Systems
MPWR
$64.7B
$45.3M 0.97%
117,848
– –
BEP icon
42
Brookfield Renewable
BEP
$9.9B
$43M 0.92%
1,236,000
– –
A icon
43
Agilent Technologies
A
$39.2B
$42.5M 0.91%
358,200
-52,200
-13% -$6.42M
CLDX icon
44
Celldex Therapeutics
CLDX
$3.02B
$39M 0.83%
1,445,700
– –
COUR icon
45
Coursera
COUR
$1.51B
$37.4M 0.8%
2,639,093
+149,919
+6% +$2.67M
NOVT icon
46
Novanta
NOVT
$4.95B
$34M 0.73%
280,000
– –
TSM icon
47
TSMC
TSM
$2.09T
$33.5M 0.72%
410,000
– –
DUOL icon
48
Duolingo
DUOL
$6.22B
$33.1M 0.71%
378,375
+120,875
+47% +$10.7M
ASML icon
49
ASML
ASML
$634B
$32.8M 0.7%
69,000
-33,600
-33% -$18.8M
KURA icon
50
Kura Oncology
KURA
$826M
$32.8M 0.7%
1,790,144
-270,900
-13% -$3.9M
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Eventide Asset Management held 149 positions worth $4.68B, down 27% from $6.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $462M in Q2 2022, closing 13 positions and reducing 54 holdings. Its most notable exit was Dynatrace, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Doximity worth $52.7M.

  • Eventide Asset Management's largest Q2 2022 buy was Doximity: 1,512,602 shares worth $52.7M.
  • Eventide Asset Management added most to ZoomInfo Technologies in Q2 2022, an estimated $19.8M increase.
  • Eventide Asset Management's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $64.6M.
  • Eventide Asset Management fully exited Dynatrace in Q2 2022, selling an estimated $112M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $4.68B portfolio in Q2 2022.
  • Eventide Asset Management opened 16 new positions and closed 13 in Q2 2022.
  • Eventide Asset Management's portfolio value fell 27% quarter-over-quarter to $4.68B.

Based on Eventide Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.